MIGRAs: Are they the new IGRAs? Development of monokine-amplified IFN-γ release assays

Biomarkers in Medicine

Volumn 6, Issue 2, 2012, Pages 177-186

  Kasprowicz, Victoria O ^a,b   Halliday, John S ^c   Mitchell, Jessica ^a,b   Klenerman, Paul ^c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

antigen specific T cell; chemokine; cytokine; IGRA; IP 10; MIG; MIGRA

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CULTURE FILTRATE PROTEIN 10; CXCL9 CHEMOKINE; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 23; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MALARIA VACCINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEGINTERFERON ALPHA; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN SPECIFICITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; CYTOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MALARIA; MICROARRAY ANALYSIS; MONOKINE AMPLIFIED GAMMA INTERFERON RELEASE ASSAY; MYCOBACTERIUM TUBERCULOSIS; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT RESPONSE;

ANIMALS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; INTERFERON-GAMMA; MONOKINES; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; TUBERCULOSIS;

EID: 84859058265     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.12.13     Document Type: Review

References (64)

1. LalVani A, Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br. Med. Bull. 93, 69-84 (2010).
2. Falconer K, Askarieh G, Weis N et al. IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV. Scand. J. Infect. Dis. 42, 896-901 (2010).
3. Reiberger T, Aberle JH, Kundi M et al. IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection. Antivir. Ther. 13, 969-976 (2008).
4. Zeremski M, Markatou M, Brown QB et al. Interferon gamma-inducible protein 10: a predictive marker of successful treatment response in hepatitis C virus/HIV-coinfected patients. J. Acquir. Immune Defic. Syndr. 45, 262-268 (2007).
5. Pokkali S, Das SD, R L. Expression of CXC and CC type of chemokines and its receptors in tuberculous and non-tuberculous effusions. Cytokine 41, 307-314 (2008).
6. Raju B, Hoshino Y, Belitskaya-Levy I et al. Gene expression profiles of bronchoalveolar cells in pulmonary TB. Tuberculosis (Edinb.) 88, 39-51 (2008).
7. Sauty A, Dziejman M, Taha RA et al. The T cell-specific CXC chemokines IP-10, MIG, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 162, 3549-3558 (1999).
8. Brice GT, Graber NL, Hoffman SL, Doolan DL. Expression of the chemokine MIG is a sensitive and predictive marker for antigen-specific, genetically restricted IFN-gamma production and IFN-gamma-secreting cells. J. Immunol. Methods 257, 55-69 (2001).
9. Azzurri A, Sow OY, Amedei A et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect. 7, 1-8 (2005).
10. Ferrero E, Biswas P, Vettoretto K et al. Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells. Immunology 108, 365-374 (2003).
11. Okamoto M, Kawabe T, Iwasaki Y et al. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions. J. Lab. Clin. Med. 145, 88-93 (2005).
12. Ruhwald M, Bodmer T, Maier C et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur. Respir. J. 32, 1607-1615 (2008).
13. Armah HB, Wilson NO, Sarfo BY et al. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar. J. 6, 147 (2007).
14. Sarkar S, Kalia V, Murphey-Corb M, Montelaro RC, Reinhart TA. Expression of IFN-gamma induced CXCR3 agonist chemokines and compartmentalization of CXCR3+ cells in the periphery and lymph nodes of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome. J. Med. Primatol. 32, 247-264 (2003).
15. Abramo C, Meijgaarden KE, Garcia D et al. Monokine induced by interferon gamma and IFN-gamma response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients. Microbes Infect. 8, 45-51 (2006).
16. Berthoud TK, Fletcher H, Porter D et al. Comparing human T cell and NK cell responses in viral-based malaria vaccine trials. Vaccine 28, 21-27 (2009).
17. Chegou NN, Black GF, Kidd M, Van Helden PD, Walzl G. Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm. Med. 9, 21 (2009).
18. Frahm M, Goswami ND, Owzar K et al. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb.) 91, 250-256 (2011).
19. Kellar KL, Gehrke J, Weis SE et al. Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS ONE 6, E26545 (2011).
20. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Eugen-Olsen J, Ravn P. IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res. Notes 2, 19 (2009).
21. Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell. Biol. 89, 207-215 (2011).
22. de Steenwinkel JE, de Knegt GJ, Ten Kate MT et al. Dynamics of interferon-gamma release assay and cytokine profiles in blood and respiratory tract specimens from mice with tuberculosis and the effect of therapy. Eur. J. Clin. Microbiol. Infect. Dis. doi:10.1007/s10096-011-1428-2 (2011) (Epub ahead of print).
23. Whiting D, Hsieh G, Yun JJ et al. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J. Immunol. 172, 7417-7424 (2004).
24. Bai X, Chmura K, Ovrutsky AR et al. Mycobacterium tuberculosis increases IP-10 and MIG protein despite inhibition of IP-10 and MIG transcription. Tuberculosis (Edinb.) 91, 26-35 (2011).
25. Seiler P, Aichele P, Bandermann S et al. Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3- signaling chemokines. Eur. J. Immunol. 33, 2676-2686 (2003).
26. Cannas A, Calvo L, Chiacchio T et al. IP-10 detection in urine is associated with lung diseases. BMC Infect. Dis. 10, 333 (2010).
27. Harvey CE, Post JJ, Palladinetti P et al. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J. Leukoc. Biol. 74, 360-369 (2003).
28. Zeremski M, Petrovic LM, Chiriboga L et al. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 48, 1440-1450 (2008).
29. Zeremski M, Dimova R, Brown Q et al. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection. J. Infect. Dis. 200, 1774-1780 (2009).
30. Zeremski M, Dimova R, Astemborski J, Thomas DL, Talal AH. CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C. J. Infect. Dis. 204, 832-836 (2011).
31. Apolinario A, Diago M, Lo Iacono O et al. Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy. Aliment. Pharmacol. Ther. 19, 551-562 (2004).
32. Diago M, Castellano G, Garcia-Samaniego J et al. Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut 55, 374-379 (2006).
33. Lagging M, Romero AI, Westin J et al. IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology 44, 1617-1625 (2006
34. Casrouge A, Decalf J, Ahloulay M et al. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J. Clin. Invest. 121, 308-317 (2011).
35. Ayimba E, Hegewald J, Segbena AY et al. Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria. Clin. Exp. Immunol. 166, 218-226 (2011).
36. Erdman LK, Dhabangi A, Musoke C et al. Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS ONE 6, E17440 (2011).
37. Jain V, Armah HB, Tongren JE et al. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar. J. 7, 83 (2008).
38. Campanella GS, Tager AM, El Khoury JK et al. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl Acad. Sci. USA 105, 4814-4819 (2008).
39. Kim TS, Chung YB, Choi HJ, Yang HJ Changes of serum cytokine profiles in Korean vivax malarial patients after chemotherapy. Parasitol. Res. 100, 183-185 (2006).
40. Dunachie SJ, Berthoud T, Keating SM, Hill AV, Fletcher HA. MIG and the regulatory cytokines IL-10 and TGF-beta1 correlate with malaria vaccine immunogenicity and efficacy. PLoS ONE 5, E12557 (2010).
41. Berthoud TK, Dunachie SJ, Todryk S, Hill AV, Fletcher HA. MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines. J. Immunol. Methods 340, 33-41 (2009).
42. Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS ONE 3, E3901 (2008).
43. Goletti D, Raja A, Ahamed Kabeer BS et al. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J. Infect. 61, 133-143 (2010).
44. Lighter J, Rigaud M, Huie M, Peng CH, Pollack H. Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int. J. Tuberc. Lung Dis. 13, 731-736 (2009).
45. Chen DY, Shen GH, Chen YM et al. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis. Int. J. Tuberc. Lung Dis. 15, 192-200 (2011).
46. Kabeer BS, Sikhamani R, Raja A. Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS 24, 323-325 (2010).
47. Ruhwald M, Bjerregaard-Andersen M, Rabna P et al. CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect. 9, 806-812 (2007).
48. Wang H, Yue J, Yang J, Gao R, Liu J. Clinical diagnostic utility of adenosine deaminase, interferon-gamma, interferon-gamma-induced protein of 10 kDa, and dipeptidyl peptidase 4 levels in tuberculous pleural effusions. Heart Lung 62(2), 186-192 (2011).
49. Trojan A, Rajeswaran R, Montemurro M, Mutsch M, Steffen R. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination. J. Clin. Virol. 40, 80-83 (2007).
50. Kasprowicz VO, Mitchell JE, Chetty S et al. A molecular assay for sensitive detection of pathogen-specific T-cells. PLoS ONE 6, E20606 (2011).
51. Chakera A, Bennett SC, Cornall RJ. A whole blood monokine-based reporter assay provides a sensitive and robust measurement of the antigen-specific T cell response. J. Transl. Med. 9, 143 (2011).
52. Goletti D, Raja A, Syed Ahamed Kabeer B et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS ONE 5, E12577 (2010).
53. SulliVan SE, Staba SL, Gersting JA et al. Circulating concentrations of chemokines in cord blood, neonates, and adults. Pediatr. Res. 51, 653-657 (2002).
54. Lande R, Giacomini E, Grassi T et al. IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J. Immunol. 170, 1174-1182 (2003).
55. Mendez Samperio P, Trejo A, Miranda E. Role of type I interferon in the bacillus Calmette-Guerin-induced expression of CXCL10 from human monocytes. Mediators Inflamm. 13, 343-348 (2004).
56. Ruhwald M, Petersen J, Kofoed K et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS ONE 3, E2858 (2008).
57. Syed Ahamed Kabeer B, Raman B, Thomas A, Perumal V, Raja A. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One 5, e9051 (2010).
58. Syed Ahamed Kabeer B, Sikhamani R, Raja A. Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects. Diagn. Microbiol. Infect. Dis. 71, 236-243 (2011).
59. Ruhwald M, Dominguez J, Latorre I et al. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb.) 91, 260-267 (2011).
60. Kasprowicz VO, Churchyard G, Lawn SD, Squire SB, LalVani A. Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas. J. Infect. Dis. 204(Suppl 4), S1168-S1178 (2011).
61. Supriya P, Chandrasekaran P, Das SD. Diagnostic utility of interferon-gamma-induced protein of 10 kDa (IP-10) in tuberculous pleurisy. Diagn. Microbiol. Infect. Dis. 62, 186-192 (2008).
62. Dheda K, Van-Zyl Smit RN, Sechi LA et al. Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS ONE 4, E4689 (2009).
63. Pokkali S, Das SD. Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis. Hum. Immunol. 70, 110-115 (2009).
64. Alsleben N, Ruhwald M, Russmann H, Marx FM, Wahn U, Magdorf K. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: A case-control study. Scand. J. Infect. Dis. doi:10.3109/00365548.2011.63 2644 (2011) (Epub ahead of print